Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied service connection for various conditions, including an acquired psychiatric disorder, tinea cruris, vision loss, and bilateral hearing loss. The claim for initial ratings was also denied.

The Board remands the claims for service connection for bilateral hearing loss, residuals of back injury, residuals of excision of ingrown toenail, left ankle sprain, and pseudofolliculitis on face to obtain additional medical opinions.

The Board granted an initial 30 percent disability rating for dermatitis, resolving reasonable doubt in favor of the Veteran.

The Board denied service connection for bilateral pes planus, bilateral tinea pedis, and rhinitis as the evidence did not support a finding that these conditions were incurred in or caused by active military service.

The Board denied increased ratings for left knee strain and right leg shin splints, granted a 10 percent rating for right ankle strain, and remanded several other issues including service connection claims.

The Board granted service connection for eczema based on toxic exposure during the Veteran's deployment to Afghanistan, as supported by a positive nexus opinion. The claim for coronary artery disease (CAD) was remanded for further evidence.

The Board granted a separate rating of 10 percent for residual scar posterior neck associated with eczema/dermatitis, but denied an increased rating greater than 10 percent for the service-connected skin conditions.

The Board granted a 30 percent rating for pseudofolliculitis barbae, with eczematous dermatitis, tinea cruris, tinea pedis and vitiligo for the period on appeal prior to April 6, 2023, but denied a higher rating for the entire period on appeal.

The Board denied an earlier effective date, a higher initial rating for scars with underlying soft tissue damage, and a compensable rating for stasis dermatitis. The IBS claim was remanded.

The Board granted the restoration of a 50 percent rating for migraine headaches, effective May 23, 2024, due to an inadequate examination that supported the previous reduction.

The Board granted an initial 10 percent rating for chronic sinusitis but remanded the issue of service connection for eczema.

The Board granted service connection for seborrheic dermatitis and remanded the claims for asthma, chronic fatigue syndrome, diabetes mellitus type 2, fibromyalgia, GERD, OSA, hemorrhoids, diarrhea, bilateral hearing loss, and tinnitus for further development.

The Board denied a rating in excess of 10 percent for tinnitus and remanded the claims for increased ratings for tension headaches, PTSD, burn scar of the right flank area, left ear hearing loss, pseudofolliculitis barbae, erectile dysfunction, and entitlement to TDIU.

The Board granted a 60 percent rating for the Veteran's skin disability, variously diagnosed as eczema or atopic dermatitis, due to the need for constant systemic therapy such as Dupixent.

The Board granted service connection for diabetes mellitus type II as secondary to the Veteran's service-connected disabilities and increased ratings of 10 percent were granted for irritable bowel syndrome (IBS) and tinea versicolor, while denying a compensable rating for allergic rhinitis and hemorrhoids.

The Veteran withdrew all of his pending appeals explicitly, unambiguously, and with a full understanding of the consequences thereof.

The Board remands the claims for further development of evidence regarding the Veteran's various service-connected skin disabilities, as the record is insufficient and at times contradictory.

The Veteran was granted an earlier effective date for the award of service connection for psoriasis, a TDIU, and denied higher initial ratings for PTSD and tinea pedis.

The Veteran withdrew his appeals for increased ratings and service connection, indicating satisfaction with the current ratings.

The Board denied the veteran's claims for increased ratings for major depressive disorder, right fibrocystic breast disease, and tinea pedis.